Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00261300|
Recruitment Status : Completed
First Posted : December 5, 2005
Last Update Posted : May 7, 2012
Gastroesophageal reflux disease (GERD) is a medical condition affecting the stomach and esophagus. GERD might occur when the lower esophageal sphincter does not close properly and stomach contents leaks back (refluxes) into the esophagus. GERD is one of the most common medical disorders, with estimates of up to 50% of adults reporting reflux symptoms. One of the main symptoms of GERD is heartburn. It occurs when the acidic content from the stomach touches the lining of the esophagus, causing a burning sensation in the chest or throat. Proton pump inhibitors such as pantoprazole can relieve symptoms of GERD and peptic ulcers in a large proportion of patients.
Additionally, long-term treatment with proton pump inhibitors may be needed for patients with chronic ulcer disease not caused by H. pylori (H. pylori is a stomach-dwelling bacteria which is often associated with ulcers in the stomach or duodenum).
The aim of the study is to evaluate the long-term effect of pantoprazole in patients with chronic gastric acid-related complaints. The study duration consists of a 5-year treatment period. Pantoprazole will be administered once daily. The study will provide further data on long-term safety, tolerability, and efficacy of pantoprazole.
|Condition or disease||Intervention/treatment||Phase|
|Gastroesophageal Reflux Disease (GERD) Peptic Ulcers||Drug: Pantoprazole||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints|
|Study Start Date :||October 2000|
|Actual Primary Completion Date :||September 2007|
|Actual Study Completion Date :||July 2008|
Pantoprazole 40 mg
Long term Pantoprozole trial
- Safety (adverse events, laboratory values). [ Time Frame: 5 years ]
- Evaluation of gastrointestinal symptoms, histological parameters. [ Time Frame: 5 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00261300
|Hannover, Germany, 30659|
|Principal Investigator:||Gorig Brunner, Prof. Dr.||30659 Hannover, Germany|